Compare CLMT & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLMT | OMCL |
|---|---|---|
| Founded | 1916 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Computer Manufacturing |
| Sector | Energy | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2006 | 2001 |
| Metric | CLMT | OMCL |
|---|---|---|
| Price | $25.31 | $36.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $21.25 | ★ $51.14 |
| AVG Volume (30 Days) | ★ 1.4M | 673.8K |
| Earning Date | 02-27-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $4,048,000,000.00 | $1,184,845,000.00 |
| Revenue This Year | $0.30 | $6.34 |
| Revenue Next Year | N/A | $4.52 |
| P/E Ratio | ★ N/A | $810.71 |
| Revenue Growth | N/A | ★ 6.53 |
| 52 Week Low | $7.68 | $22.66 |
| 52 Week High | $25.39 | $55.00 |
| Indicator | CLMT | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 83.81 | 24.02 |
| Support Level | $21.26 | $36.94 |
| Resistance Level | $25.32 | $50.19 |
| Average True Range (ATR) | 0.96 | 2.01 |
| MACD | 0.36 | -1.54 |
| Stochastic Oscillator | 91.73 | 9.82 |
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.